机构

• 上海药物研究所 [23]
• 金属研究所 [11]
• 上海生物化学与细胞生... [4]
• 大连化学物理研究所 [2]
• 上海应用物理研究所 [2]
• 昆明植物研究所 [1]
• 更多

采集方式

• OAI收割 [43]
• iSwitch采集 [1]

内容类型

• 期刊论文 [42]
• 会议论文 [1]
• 学位论文 [1]

发表日期

• 2023 [1]
• 2022 [1]
• 2021 [1]
• 2020 [3]
• 2019 [3]
• 2018 [6]
• 更多

学科主题

• Hematology... [3]
• Biochemist... [1]

筛选

浏览/检索结果: 共44条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 页码: 18 作者:  Ren, Pengxuan;  Li, Hui;  Nie, Tianqing;  Jian, Xiaoqin;  Yu, Changyue   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/10/17 抗血小板活性松香烷二萜的合成、结构优化及机制研究 学位论文  OAI收割 : 中国科学院大学, 2022 作者:  夏凡   |  收藏  |  浏览/下载：0/0  |  提交时间：2024/05/14 康定鼠尾草，松香烷二萜，抗血小板活性，合成和结构优化研究  Salvia prattii, Abietane diterpenoid, Antiplatelet aggregation activity, Synthesis and structure optimization   Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis 期刊论文  OAI收割 JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2021, 卷号: 2021, 页码: 9934535 作者:  Xu, Yi;  Shen, Yimin;  Chen, Delong;  Zhao, Pengfei;  Jiang, Jun   |  收藏  |  浏览/下载：10/0  |  提交时间：2024/03/21 Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng   |  收藏  |  浏览/下载：29/0  |  提交时间：2021/05/24 vicagrel  [C-14]vicagrel  vicagrel pharmacokinetics  vicagrel metabolism  mass balance  P2Y(12) receptor inhibitor   Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200 期刊论文  OAI收割 JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 页码: 10 作者:  Zhu, Shuhao;  Gilbert, James C.;  Liang, Zicai;  Kang, Daiwu;  Li, Ming   |  收藏  |  浏览/下载：26/0  |  提交时间：2020/12/24 glycoprotein Ib  platelet  reversal agent  thrombosis  von Willebrand factor   Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12inhibitor 期刊论文  OAI收割 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 卷号: 86, 期号: 9, 页码: 1860-1874 作者:  Zhang, Yifan;  Zhu, Xiaoxue;  Zhan, Yan;  Li, Xiaojiao;  Liu, Cai   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/03/21 P2Y(12)inhibitor  pharmacodynamics  pharmacokinetics  vicagrel   Rhodium-Catalyzed Asymmetric Addition of Arylboronic Acids to Glyoxylates: Access to Optically Active Substituted Mandelic Acid Esters 期刊论文  OAI收割 SYNLETT, 2019, 卷号: 30, 期号: 14, 页码: 1693-1697 作者:  Chen, Diao;  Liu, Jian-Guo;  Zhang, Xu;  Xu, Ming-Hua   |  收藏  |  浏览/下载：22/0  |  提交时间：2024/03/21 asymmetric catalysis  rhodium catalysis  ligands  mandelic acid esters  glyoxylate  arylboronic acids   Optimization of P2Y(12) Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbarnoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 6, 页码: 3088-3106 作者:  Kong, Deyu;  Xue, Tao;  Guo, Bin;  Cheng, Jianjun;  Liu, Shunyin   |  收藏  |  浏览/下载：12/0  |  提交时间：2020/07/01 Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127, 页码: 151-160 作者:  Li, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei   |  收藏  |  浏览/下载：102/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  P2Y(12) inhibitor  Pharmacokinetics  Active metabolite  Thienopyridine   Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y(1) receptor antagonists 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 158, 页码: 302-310 作者:  Peng, Jingjing;  Zhao, Lifen;  Wang, Lanlan;  Chen, Hui;  Qiu, Yunguang   |  收藏  |  浏览/下载：47/0  |  提交时间：2019/01/08 P2Y(1) receptor antagonist  2-(phenoxyaryl)-3-urea derivatives  Anti-Platelet